Your browser doesn't support javascript.
loading
Incidence of subsequent malignancies after total body irradiation-based allogeneic HSCT in children with ALL - long-term follow-up from the prospective ALL-SCT 2003 trial.
Eichinger, Anna; Poetschger, Ulrike; Glogova, Evgenia; Bader, Peter; Basu, Oliver; Beier, Rita; Burkhardt, Birgit; Classen, Carl-Friedrich; Claviez, Alexander; Corbacioglu, Selim; Deubzer, Hedwig E; Greil, Johann; Gruhn, Bernd; Güngör, Tayfun; Kafa, Kinan; Kühl, Jörn-Sven; Lang, Peter; Lange, Bjoern Soenke; Meisel, Roland; Müller, Ingo; Sauer, Martin G; Schlegel, Paul-Gerhardt; Schulz, Ansgar; Stachel, Daniel; Strahm, Brigitte; Wawer, Angela; Peters, Christina; Albert, Michael H.
Afiliação
  • Eichinger A; Department of Pediatrics, Dr. von Hauner Children's Hospital, University Hospital, LMU, Munich, Germany.
  • Poetschger U; Children's Cancer Research Institute, Vienna, Austria.
  • Glogova E; Children's Cancer Research Institute, Vienna, Austria.
  • Bader P; Division for Stem Cell Transplantation and Immunology, Department for Children and Adolescents, University Hospital, Goethe University, Frankfurt/Main, Germany.
  • Basu O; Department of Pediatrics III, University Hospital Essen, University Medicine Essen, Essen, Germany.
  • Beier R; Department of Pediatric Oncology and Hematology, Medizinische Hochschule Hannover, Hannover, Germany.
  • Burkhardt B; Pediatric Hematology and Oncology, University Hospital Muenster, Muenster, Germany.
  • Classen CF; Oncology and Hematology Unit, Children's Hospital, University Medicine Rostock, Rostock, Germany.
  • Claviez A; Department of Pediatrics and Bone Marrow Transplant Unit, Medical University of Schleswig-Holstein, Campus Kiel, Kiel, Germany.
  • Corbacioglu S; Department of Pediatric Hematology, Oncology and Stem Cell Transplantation, University of Regensburg, Regensburg, Germany.
  • Deubzer HE; Department of Pediatric Hematology and Oncology, Charité - Universitätsmedizin Berlin, Corporate Member of Freie Universität Berlin and Humboldt-Universität Berlin, Berlin, Germany.
  • Greil J; Experimental and Clinical Research Center (ECRC) of the Charité and the Max-Delbrück-Center for Molecular Medicine (MDC) in the Helmholtz Association, Berlin, Germany.
  • Gruhn B; Department of Pediatric Oncology, Hematology and Immunology, University of Heidelberg, Heidelberg, Germany.
  • Güngör T; Department of Pediatrics, Jena University Hospital, Jena, Germany.
  • Kafa K; Department of Hematology/Oncology/Immunology, Gene-therapy, and Stem Cell Transplantation, University Children's Hospital Zurich - Eleonore Foundation & Children's Research Center (CRC), Zurich, Switzerland.
  • Kühl JS; Department of Pediatrics, University of Halle, Halle, Germany.
  • Lang P; Department of Pediatric Oncology, Hematology and Hemostaseology, University of Leipzig, Leipzig, Germany.
  • Lange BS; University Children's Hospital, Tübingen, Germany.
  • Meisel R; Department of Pediatrics, University Hospital Carl Gustav Carus, Technical University of Dresden, Dresden, Germany.
  • Müller I; Division of Pediatric Stem Cell Therapy, Department of Pediatric Oncology, Hematology and Clinical Immunology, Medical Faculty, Heinrich-Heine-University, Düsseldorf, Germany.
  • Sauer MG; Divison of Pediatric Stem Cell Transplantation and Immunology, Clinic for Pediatric Hematology and Oncology, University Medical Center Hamburg-Eppendorf, Hamburg, Germany.
  • Schlegel PG; Department of Pediatric Oncology and Hematology, Medizinische Hochschule Hannover, Hannover, Germany.
  • Schulz A; Department of Pediatric Hematology and Oncology, University Children's Hospital Würzburg, Würzburg, Germany.
  • Stachel D; Department of Pediatrics, University Medical Center Ulm, Ulm, Germany.
  • Strahm B; Children's Hospital, Universitätsklinikum Erlangen, Erlangen, Germany.
  • Wawer A; Division of Pediatric Hematology and Oncology, Department of Pediatrics and Adolescent Medicine, Medical Center, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
  • Peters C; Department of Pediatrics and Children's Cancer Research Center, Kinderklinik München Schwabing, Technical University of Munich School for Medicine, Munich, Germany.
  • Albert MH; St. Anna Children's Hospital, University Vienna, St. Anna Children's Cancer Research Institute, Vienna, Austria.
Leukemia ; 36(11): 2567-2576, 2022 11.
Article em En | MEDLINE | ID: mdl-36097283
Assuntos
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro / Neoplasias Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Transplante de Células-Tronco Hematopoéticas / Doença Enxerto-Hospedeiro / Neoplasias Tipo de estudo: Etiology_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Child / Humans Idioma: En Ano de publicação: 2022 Tipo de documento: Article